LU84359A1 - Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain - Google Patents

Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain Download PDF

Info

Publication number
LU84359A1
LU84359A1 LU84359A LU84359A LU84359A1 LU 84359 A1 LU84359 A1 LU 84359A1 LU 84359 A LU84359 A LU 84359A LU 84359 A LU84359 A LU 84359A LU 84359 A1 LU84359 A1 LU 84359A1
Authority
LU
Luxembourg
Prior art keywords
human
insulin
peptide
units
composition
Prior art date
Application number
LU84359A
Other languages
English (en)
French (fr)
Inventor
Bruce Hill Frank
Ronald Eugene Chance
John Allison Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU84359A1 publication Critical patent/LU84359A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
LU84359A 1981-08-27 1982-08-26 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain LU84359A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27
US29671581 1981-08-27

Publications (1)

Publication Number Publication Date
LU84359A1 true LU84359A1 (fr) 1983-02-28

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84359A LU84359A1 (fr) 1981-08-27 1982-08-26 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain

Country Status (20)

Country Link
JP (1) JPS5846024A (de)
AU (1) AU551879B2 (de)
BE (1) BE894185A (de)
CA (1) CA1176158A (de)
CH (1) CH650679A5 (de)
DE (1) DE3232034A1 (de)
DZ (1) DZ452A1 (de)
FR (1) FR2513126B1 (de)
GB (1) GB2104382B (de)
IE (1) IE54119B1 (de)
IL (1) IL66611A0 (de)
IT (1) IT1153182B (de)
LU (1) LU84359A1 (de)
MW (1) MW3882A1 (de)
NL (1) NL192192C (de)
NZ (1) NZ201682A (de)
PH (1) PH19361A (de)
SE (1) SE460334B (de)
ZA (1) ZA826159B (de)
ZW (1) ZW17482A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
JPH01501389A (ja) * 1986-10-20 1989-05-18 ノボ　インダストリ　アクティーゼルスカブ ポリペプチド製剤
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
WO1988006599A1 (en) * 1987-02-25 1988-09-07 Novo Industri A/S Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
ATE63821T1 (de) * 1987-08-14 1991-06-15 Akzo Nv Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
CN101060856B (zh) * 2004-11-22 2011-01-19 诺和诺德公司 可溶、稳定的含胰岛素制剂
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
EP2350118B1 (de) 2008-09-19 2016-03-30 Nektar Therapeutics Kohlenhydratbasisierte polymere zur wirkstoffabgabe und konjugate davon
EP2571896A4 (de) 2010-05-17 2014-01-08 Cebix Inc Pegyliertes c-peptid
WO2013075117A2 (en) 2011-11-17 2013-05-23 John Wahren Pegylated c-peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
CH650679A5 (de) 1985-08-15
CA1176158A (en) 1984-10-16
IT1153182B (it) 1987-01-14
IE54119B1 (en) 1989-06-21
AU8759482A (en) 1983-03-03
DE3232034A1 (de) 1983-03-10
BE894185A (fr) 1983-02-24
MW3882A1 (en) 1984-07-11
FR2513126A1 (fr) 1983-03-25
NL192192B (nl) 1996-11-01
PH19361A (en) 1986-04-02
DZ452A1 (fr) 2004-09-13
ZA826159B (en) 1984-04-25
NL8203315A (nl) 1983-03-16
SE8204873D0 (sv) 1982-08-25
SE8204873L (sv) 1983-02-28
IE822064L (en) 1983-02-27
IL66611A0 (en) 1982-12-31
NZ201682A (en) 1985-08-16
DE3232034C2 (de) 1991-04-11
ZW17482A1 (en) 1982-11-17
AU551879B2 (en) 1986-05-15
FR2513126B1 (fr) 1986-04-18
NL192192C (nl) 1997-03-04
GB2104382A (en) 1983-03-09
SE460334B (sv) 1989-10-02
IT8223017A0 (it) 1982-08-27
JPS5846024A (ja) 1983-03-17
GB2104382B (en) 1984-12-19

Similar Documents

Publication Publication Date Title
JP2828250B2 (ja) 真性糖尿病の治療
BE1009408A5 (fr) Formulations d'analogues de l'insuline.
ES2271458T3 (es) Efectores de dipeptidil peptidasa iv.
LU84359A1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain
US7423014B2 (en) Insulin conjugates for treating diabetes mellitus
LU84356A1 (fr) Formulations pharmaceutiques comprenant de l'insuline et de la pro-insuline humaines
US7485620B2 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
ZA200406332B (en) ACC inhibitors.
JPWO2004037859A1 (ja) Ｇｌｐ−１誘導体及びその経粘膜吸収型製剤
US4652548A (en) Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
US7601688B2 (en) Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
CN111712236A (zh) 用于治疗糖尿病的包含基于脂质的纳米颗粒的组合物
LU84358A1 (fr) Formulations pharmaceutiques de pro-insuline humaine
LU84357A1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine,un c-peptide humain et de la pro-insuline humaine
KR20200130297A (ko) 비만의 치료 및 체중 관리를 위한 glp-1 조성물
NZ546912A (en) Use of C-peptides in manufacture of a medicament in once daily dose for treating diabetes and microvascular complications
FR2638968A1 (fr) Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives
FR2746313A1 (fr) Utilisation de la melatonine et des ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention et au traitement du diabete et des complications diabetiques
BE1013507A5 (fr) Formulations d'analogues de l'insuline.
Meeran Hypothalamic peptides in the regulation of feeding and peripheral metabolism
Ladley The Role of Oral Growth Hormone Secretagogues in Anti-Aging Therapy